BioAtla Inc.
BCAB | NASDAQ
$1.74
+$0.42 (+31.82%)
Aug 28, 2026, 4:00 PM ET · Market open
Market Data
Market Cap $2.88M
Enterprise Value $7.2M
Beta 0.76
Average Volume 50.18K
Shares Outstanding (Diluted) 1.66M
Shares Change YoY 42.02%
Institutional Ownership 20.48%
Exchange NASDAQ
ISIN US09077B2034
Price Performance
Price Change 1M -49.4%
Price Change 3M -50.1%
Price Change 6M -79.3%
Price Change YTD -93.5%
Price Change 1Y -92.2%
Price Change 3Y -98.5%
Price Change 5Y -99.9%
1M CAGR (ann.) -42.9%
1Y CAGR (ann.) -94.7%
5Y CAGR (ann.) -74.9%
All-Time CAGR -68.8%
Valuation
PE Ratio -0.07
Forward PE N/A
PEG Ratio -0.00
Forward PEG -0.00
PS Ratio 1.44
Forward PS 0.80
PB Ratio -0.08
P/FCF Ratio -0.12
P/Adj. FCF Ratio -0.10
P/OCF Ratio -0.12
EV/Sales 3.60
EV/EBIT -0.24
EV/EBITDA -0.25
EV/FCF -0.31
Earnings Yield -1462.6%
FCF Yield -815.5%
Adj. FCF Yield -954.0%
Financial Health
Net Debt $4.32M
Total Debt $5.86M
Cash & Short-Term Investments $1.54M
Total Assets $9.51M
Current Ratio 0.20
Quick Ratio 0.20
Debt / Equity Ratio -0.16
Debt / EBITDA -0.20
Debt / FCF -0.25
OCF / Debt -4.01
Interest Coverage 0.00
Altman Z-Score -93.30
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -4.2%
Operating Profit Margin -1581.3%
EBITDA Margin -343.2%
Net Profit Margin -370.1%
FCF Margin -1174.1%
Adj. FCF Margin -1373.5%
SBC / Revenue 46.9%
SBC Impact (per share) -17.0%
Returns
Return on Assets -330.9%
Return on Equity 89.3%
Return on Invested Capital 318.0%
Return on Capital Employed 274.6%
Return on Tangible Assets -330.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 23.1%
Revenue CAGR 5Y 38.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 66.2%
EPS CAGR 5Y 33.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y 68.7%
FCF CAGR 5Y 20.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y -29.5%
Revenue Growth Next 3Y 392.8%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$7
EPS Growth Est (next Q) -48.1%
Revenue Est (next Q) $5.59M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $250
Price Target Upside 14267.8%
Cash Flow
Operating Cash Flow $-23.48M
Free Cash Flow $-23.48M
Adj. Free Cash Flow $-27.47M
FCF Per Share -$14.14
OCF Per Share -$14.14
OCF/S Ratio -276.3%
Income Statement
Revenue $2M
Gross Profit $-6.85M
Operating Income $-31.63M
EBITDA $-28.97M
Net Income $-31.45M
EPS (Diluted) -$25.45
Revenue / Employee $48.78K
Profit / Employee $-767.17K
Employees 41
Add to Watchlist
Select watchlists to add or remove BCAB